TY - JOUR
AU - Mitchell, E.J.
AU - Ahmed, Khaled
AU - Breeman, Suzanne
AU - Cotton, Seonaidh
AU - Constable, Lynda
AU - Ferry, Gillian
AU - Goodman, Kirsteen
AU - Hickey, Helen
AU - Meakin, Garry
AU - Mironov, Katy
AU - Quann, Niamh
AU - Wakefield, Natalie
AU - McDonald, Alison
PY - 2020
DA - September
TI - It is unprecedented: trial management during the COVID-19 pandemic and beyond
JO - BMC Trials
VL - 21
DO - https://doi.org/10.1186/s13063-020-04711-6
AB - The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete pause or pause in some activities) and/or adapting their processes. Trial managers have played a key role in decision-making, undertaking risk assessments and adapting trial processes, working closely with other members of the research team. This article presents some of the ways in which trial management processes have been altered and the key role that trial managers have played. It has been born out of discussions between trial managers in the UK who are members of the UK Trial Managers’ Network (UKTMN), a national network of trial management professionals managing non-commercial trials.
PB - Springer Nature
UR - https://aura.abdn.ac.uk/handle/2164/15134
KW - Coronavirus (COVID-19)
ER